Harpoon Therapeutics, Inc. Profile Avatar - Palmy Investing

Harpoon Therapeutics, Inc.

Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United…

Biotechnology
US, South San Francisco [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared Harpoon Therapeutics, Inc. (HARP) to it's peer group.

Peer Group
Loading...
End of HARP's Analysis
CIK: 1708493 CUSIP: 41358P106 ISIN: US41358P2056 LEI: - UEI: -
Secondary Listings
HARP has no secondary listings inside our databases.